ReShape Lifesciences Inc. Financial Ratios — RSLS Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-63.19	-73.05	-80.09	-98.24	-128.17	-196.35	-250.82	-70.64	-120.25	-172.72	-56.39	-140.96	-145.16	-104.44	-92.26
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	25.67	- -	- -	57.18	45.15	41.44	72.98	61.67	55.42	61.38	60.52	63.93	63.17
EBITDA Margin (%)	- -	- -	-7,166.12	- -	- -	-9,478.53	-2,880.03	-4,881.94	-3,970.51	-93.98	-95.5	-185.75	-221.75	-166.92	-83.01
Operating Margin (%)	- -	- -	-7,239	- -	- -	-9,543.42	-2,897.77	-4,929.06	-4,043	-105.29	-110.25	-200.24	-240.91	-168.69	-83.29
Incremental Operating Margin (%)	- -	- -	- -	701.57	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-7,531.5	- -	- -	-8,732.45	-2,969.62	-5,759.18	-6,377.92	-497.71	-193.03	-466.32	-414.54	-130.62	-88.57
Profit Margin (%)	- -	- -	-7,531.5	- -	- -	-8,732.45	-2,969.62	-5,941.73	-13,369.36	-491.8	-191.43	-464.31	-411.16	-131.22	-89.06
Net Income to Common Margin (%)	- -	- -	-7,531.5	- -	- -	-8,732.45	-2,969.62	-5,941.73	-13,369.36	-491.8	-191.43	-464.31	-411.16	-131.22	-89.06
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	6	5	10	7	3	1	- -	- -	- -	1	13	- -	- -	- -	1
ST Debt	1	2	3	4	3	1	- -	- -	- -	- -	4	- -	- -	- -	1
LT Debt	5	3	7	3	- -	1	- -	- -	- -	- -	9	- -	- -	- -	- -
Total Debt/EBITDA	-0.37	-0.21	-0.43	-0.28	-0.12	-0.05	- -	- -	- -	-0.05	-1.23	-0.01	-0.01	-0.02	-0.15
Net Debt/EBITDA	1.58	0.93	0.57	0.67	0.34	0.24	0.15	0.37	0.23	0.21	-0.91	0.9	0.15	0.31	-0.02
Total Debt/EBIT	-0.37	-0.21	-0.43	-0.28	-0.12	-0.05	- -	- -	- -	-0.05	-1.06	-0.01	-0.01	-0.02	-0.15
Net Debt/EBIT	1.54	0.92	0.56	0.66	0.34	0.24	0.15	0.36	0.23	0.18	-0.79	0.84	0.14	0.3	-0.02
EBITDA to Interest Expense	-12.56	-34.52	-24.75	-26.34	-47.91	-29.47	-5.52	-9,895.32	-2,008.42	-31.44	-5.27	-30.36	-220.58	- -	- -
EBITDA-CapEx/Interest Expense	-12.56	-34.87	-24.84	-26.79	-48.08	-29.51	-5.52	-9,944.16	-2,012.5	-31.47	-5.27	-30.36	-220.58	- -	- -
EBIT to Interest Expense	-12.86	-34.94	-25	-26.53	-48.27	-29.67	-5.55	-9,990.82	-2,045.08	-35.23	-6.08	-32.73	-239.63	- -	- -
Interest Expense	1	1	1	1	1	1	4	- -	- -	- -	2	1	- -	- -	- -
Common Equity/Total Assets	-388.85	-542.84	-765.44	-853.87	-1,752	-2,395.59	-4,273.86	-377.39	-905.47	-1,243.69	-1,389.12	-1,100.25	-5,602.1	-5,960.56	-13,409.22
Long-Term Debt/Equity (%)	16.77	14.38	56.29	19.54	- -	14.97	- -	- -	- -	1.98	64.41	- -	- -	2.27	- -
Long-Term Debt/Capital (%)	-3.45	-1.68	-3.52	-1.31	- -	-0.2	- -	- -	- -	-0.1	-1.86	- -	- -	-0.02	-0.01
Long-Term Debt/Total Assets (%)	12.88	8.87	25.61	10.87	- -	4.74	- -	- -	- -	1.2	25.18	- -	- -	1.42	0.86
Total Debt/Equity (%)	19.88	25.89	81.55	46.79	44.66	34.5	- -	- -	- -	3.19	91.48	0.63	4.67	3.93	-382.21
Total Debt/Capital (%)	-4.09	-3.03	-5.09	-3.14	-1.19	-0.46	- -	- -	- -	-0.16	-2.64	-0.05	-0.03	-0.04	-0.15
Total Debt/Total Assets (%)	15.26	15.97	37.11	26.03	20.69	10.94	- -	- -	- -	1.94	35.76	0.53	1.53	2.46	20.18
Net Debt to Equity	-83.94	-116.26	-106.32	-111.92	-129.69	-181.3	-112.67	-13.31	-17.52	-12.17	67.78	-51.35	-105.3	-66.92	-46.64
Net Debt/Capital (%)	14.22	11.67	5.94	6.8	3.32	2.34	1.09	2.95	1.31	0.59	-1.95	3.79	0.61	0.7	-0.02
EBITDA	-16	-25	-22	-25	-25	-28	-23	-28	-24	-14	-11	-25	-25	-14	-7
EBITDA-CapEx	-16	-25	-22	-25	-25	-28	-23	-28	-24	-14	-11	-25	-25	-14	-7
Operating Income (Loss)	-16	-25	-23	-25	-26	-28	-23	-28	-25	-16	-12	-27	-27	-15	-7

Liquidity (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	7.72	3.08	2.96	2.64	1.5	1.77	0.81	1.44	0.66	0.28	0.25	3.02	0.52	1.18	0.14
Current Ratio	9.46	3.3	3.24	2.83	1.69	2.34	1.41	1.98	1.04	0.97	0.77	3.98	1.32	2.73	0.92
Quick Ratio	7.72	3.08	2.97	2.64	1.51	1.78	0.85	1.51	0.77	0.68	0.48	3.4	0.81	1.63	0.35
CFO/Avg Current Liab	-2.66	-2.94	-2.63	-2.25	-2.34	-3.7	-4.83	-4.43	-3.57	-1.51	-0.78	-1.61	-2.92	-3.01	-1.01
Common Equity/Total Assets	-388.85	-542.84	-765.44	-853.87	-1,752	-2,395.59	-4,273.86	-377.39	-905.47	-1,243.69	-1,389.12	-1,100.25	-5,602.1	-5,960.56	-13,409.22
Long-Term Debt/Equity (%)	16.77	14.38	56.29	19.54	- -	14.97	- -	- -	- -	1.98	64.41	- -	- -	2.27	- -
Long-Term Debt/Capital (%)	-3.45	-1.68	-3.52	-1.31	- -	-0.2	- -	- -	- -	-0.1	-1.86	- -	- -	-0.02	-0.01
Long-Term Debt/Total Assets (%)	12.88	8.87	25.61	10.87	- -	4.74	- -	- -	- -	1.2	25.18	- -	- -	1.42	0.86
Total Debt/Equity (%)	19.88	25.89	81.55	46.79	44.66	34.5	- -	- -	- -	3.19	91.48	0.63	4.67	3.93	-382.21
Total Debt/Capital (%)	-4.09	-3.03	-5.09	-3.14	-1.19	-0.46	- -	- -	- -	-0.16	-2.64	-0.05	-0.03	-0.04	-0.15
Total Debt/Total Assets (%)	15.26	15.97	37.11	26.03	20.69	10.94	- -	- -	- -	1.94	35.76	0.53	1.53	2.46	20.18
CFO/Total Liabilities	-152.16	-160.19	-158.06	-157.37	-251.04	-285.66	-503.52	-199.29	-188.16	-91.32	-37.88	-187.57	-292.77	-424	-87.73
CFO/CapEx	-5,271.84	-79.02	-294.26	-44.29	-218.58	-580.91	-1,475.41	-179.31	-561.02	-1,014.29	- -	- -	- -	- -	- -
Altman's Z-Score	-5.79	-9.37	-12.8	-14.35	-29.96	-40.83	-41.98	74.85	13,441.7	6,180.5	53,400.36	-24.95	-86.93	-86.21	-190.48

Working Capital (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	11.89	- -	- -	9.61	7.8	1.44	0.68	5.07	2.69	3.59	3.42	3.43	3.67
Days Sales Outstanding	- -	- -	30.7	- -	- -	37.96	46.77	252.73	540.43	72.06	135.56	101.65	106.79	106.27	99.57
Inventory Turnover	- -	- -	0.2	- -	- -	0.09	0.25	0.18	0.11	5.03	2.83	2	1.34	0.85	0.95
Days Inventory Outstanding	- -	- -	1,844.42	- -	- -	3,892.13	1,470.19	2,057.93	3,286.72	72.63	129.02	182.33	271.98	428.67	383.75
Accounts Payable Turnover	- -	3.82	1.12	-0.61	-0.56	2.91	0.72	0.43	-0.6	2.08	1.51	1.69	1.87	1.8	0.86
Accounts Payable Turnover Days	- -	95.57	325.81	-596.02	-651.98	125.51	506.4	855.05	-604.65	175.76	242.29	216.26	195.09	202.37	426.38
Cash Conversion Cycle	- -	- -	1,549.31	- -	- -	3,804.58	1,010.57	1,455.6	4,431.8	-31.06	22.29	67.71	183.68	332.56	56.94
Inventory to Cash Days	- -	- -	-1,813.71	- -	- -	-3,854.16	-1,423.42	-1,805.2	-2,746.29	-0.57	6.54	-80.68	-165.19	-322.41	-284.18
Inventories	- -	1	1	1	1	2	2	2	1	1	2	3	4	4	2
Raw Materials	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	1	2	2	2	2
Work In Process	- -	1	1	1	1	1	1	1	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	2	1	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	192	1,754	329,042	161,886	2,011,835	29	3	1	2
- Cash & Cash Equivalents	31	28	22	23	12	8	3	10	6	3	3	23	4	4	1
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	6	5	10	7	3	1	- -	- -	- -	1	13	- -	- -	- -	1
Enterprise Value	-25	-24	-13	-16	-9	-7	189	1,744	329,036	161,884	2,011,845	7	- -	-3	3
Total Capital	-145	-171	-190	-218	-249	-276	-301	-335	-419	-492	-502	-578	-624	-635	-642
Total Debt/Capital (%)	-4.09	-3.03	-5.09	-3.14	-1.19	-0.46	- -	- -	- -	-0.16	-2.64	-0.05	-0.03	-0.04	-0.15
Total Debt / EV	-0.24	-0.21	-0.77	-0.42	-0.34	-0.19	- -	- -	- -	- -	- -	0.04	-0.92	-0.1	0.38
EV/Sales	- -	- -	- -	- -	- -	- -	240.48	3,063.81	542,069.76	10,728.59	178,055.18	0.49	6.03	3.8	0.32
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	192	1,754	329,042	161,886	2,011,835	29	3	1	2
Diluted Enterprise Value	-25	-23	-13	-16	-9	-7	189	1,744	329,036	161,884	2,011,845	7	- -	-3	3
EV per Share	- -	- -	- -	- -	- -	- -	18,917,638.3	14,293,428.34	4,502,166.6	413,243.72	326,251.17	27,120.16	9,269.51	321.14	124.79
TTM Sales	- -	- -	- -	- -	- -	- -	1	1	1	15	11	14	11	9	8
TTM EBITDA	-16	-25	-22	-25	-25	-28	-23	-28	-24	-14	-11	-25	-25	-14	-7
TTM Operating Income	-16	-25	-23	-25	-26	-28	-23	-28	-25	-16	-12	-27	-27	-15	-7
TTM Cash Flow to Firm	-12	-19	-22	-17	-19	-22	-17	-25	-27	-14	-7	-15	-22	-17	-4
TTM Free Cash Flow to Firm	-12	-19	-22	-17	-19	-22	-17	-24	-27	-14	-7	-15	-22	-17	-4

Multiples (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	-9.33	-71.73	-11,990.89	-11,411.66	-235,302.36	-1.89	-0.16	-0.09	-0.52
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-25	-24	-13	-16	-9	-7	189	1,744	329,036	161,884	2,011,845	7	- -	-3	3
Low Price	- -	- -	- -	- -	- -	- -	17,987,219	14,211,643	3,175,494.5	330,599.5	134,849.75	116,724.75	7,830	269	102.25
EV/Sales	- -	- -	- -	- -	- -	- -	240.48	3,063.81	542,069.76	10,728.59	178,055.18	0.49	6.03	3.8	0.32
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	-10.51	-74.15	-5,868.09	-8,592.8	-66,453.56	-1.73	-0.39	-1.2	-0.68
Price/Earnings High	- -	- -	- -	- -	- -	- -	-14.78	-103.42	-16,032.46	-26,749.18	-194,083.59	-9.09	-1.04	-10.79	-2.1
Price/Earnings Low	- -	- -	- -	- -	- -	- -	-7.7	-51.27	-2,859.79	-1,745.24	-38,444.67	-0.45	-0.06	-0.1	-0.3
Price/Book Value	- -	- -	- -	- -	- -	- -	-0.64	-5.24	-785.32	-328.24	-3,907.82	-0.05	-0.01	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	-0.82	-7.49	-1,136.56	-1,292.88	-2,792.01	-0.19	-0.03	-0.02	-0.01
Price/Book Value High	- -	- -	- -	- -	- -	- -	-1.15	-10.45	-3,105.24	-4,024.71	-8,154.31	-0.99	-0.08	-0.19	-0.02
Price/Book Value Low	- -	- -	- -	- -	- -	- -	-0.6	-5.18	-553.9	-262.59	-1,615.23	-0.05	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	65.5	43.25	-62,496.09	-35,439.11	-160,497.42	1.24	1.03	0.22	-9.09
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	83.52	61.84	-90,447.74	-139,589.68	-114,670.16	4.65	5.28	2.05	-19.09
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	117.54	86.24	-247,116.15	-434,539.49	-334,904.51	24.41	14.19	18.44	-59.09
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	61.21	42.76	-44,079.36	-28,351.3	-66,338.91	1.22	0.82	0.17	-8.33
Price/Sales	- -	- -	- -	- -	- -	- -	244.69	3,081.66	542,078.9	10,728.73	178,054.27	2.14	0.31	0.17	0.29
Price/Sales Average	- -	- -	- -	- -	- -	- -	311.99	4,405.94	784,526.08	42,258.97	127,213.95	8.04	1.6	1.57	0.6
Price/Sales High	- -	- -	- -	- -	- -	- -	439.06	6,144.68	2,143,437.41	131,551.22	371,539.79	42.2	4.3	14.16	1.87
Price/Sales Low	- -	- -	- -	- -	- -	- -	228.65	3,046.28	382,335.82	8,582.99	73,595.74	2.1	0.25	0.13	0.26
Price/Cash Flow	- -	- -	- -	- -	- -	- -	-9.32	-71.33	-11,969.51	-11,400.41	-235,302.36	-1.89	-0.16	-0.09	-0.52
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	-11.88	-101.99	-17,322.93	-44,904.62	-168,115.84	-7.11	-0.82	-0.81	-1.09
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	-16.72	-142.24	-47,328.72	-139,787.07	-490,997.44	-37.33	-2.2	-7.25	-3.38
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	-8.71	-70.51	-8,442.26	-9,120.33	-97,258.28	-1.86	-0.13	-0.07	-0.48
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	-11.89	-102.56	-17,353.86	-44,948.94	-168,115.84	-7.11	-0.82	-0.81	-1.09
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	-16.73	-143.03	-47,413.23	-139,925.02	-490,997.44	-37.33	-2.2	-7.25	-3.38
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	-8.71	-70.91	-8,457.34	-9,129.33	-97,258.28	-1.86	-0.13	-0.07	-0.48
EV/Sales Average	- -	- -	- -	- -	- -	- -	307.79	4,388.09	784,516.94	42,258.83	127,214.86	6.39	1.27	1.09	0.64
EV/Sales High	- -	- -	- -	- -	- -	- -	434.85	6,126.83	2,143,428.27	131,551.08	371,540.7	40.55	3.97	13.68	1.9
EV/Sales Low	- -	- -	- -	- -	- -	- -	224.44	3,028.42	382,326.68	8,582.85	73,596.65	0.45	4.77	2.7	0.3
EV/EBITDA Average	1.58	0.93	0.57	0.67	0.34	0.24	-10.69	-89.88	-19,758.59	-44,964.63	-133,216.01	-3.44	-0.57	-0.65	-0.77
EV/EBITDA High	1.58	0.93	0.57	0.67	0.34	0.24	-15.1	-125.5	-53,983.69	-139,974.21	-389,067.51	-21.83	-1.79	-8.19	-2.29
EV/EBITDA Low	1.58	0.93	0.57	0.67	0.34	0.24	-7.79	-62.03	-9,629.16	-9,132.4	-77,068.45	-0.24	0.04	0.21	-0.36
EV/EBIT Average	1.54	0.92	0.56	0.66	0.34	0.24	-10.62	-89.02	-19,404.33	-40,136.18	-115,388.99	-3.19	-0.53	-0.65	-0.77
EV/EBIT High	1.54	0.92	0.56	0.66	0.34	0.24	-15.01	-124.3	-53,015.81	-124,943.3	-337,002.36	-20.25	-1.65	-8.11	-2.28
EV/EBIT Low	1.54	0.92	0.56	0.66	0.34	0.24	-7.75	-61.44	-9,456.51	-8,151.73	-66,755.12	-0.22	0.03	0.21	-0.36
Last Price	- -	- -	- -	- -	- -	- -	19,248,717	14,376,725	4,502,242.5	413,249.25	326,249.5	118,899.75	9,773	362	111.5
High Price	- -	- -	- -	- -	- -	- -	34,538,941	28,666,451	17,802,344	5,067,089	680,773.75	2,342,471	134,849.75	29,913.5	725
Enterprise Value Average	-25	-23	-13	-16	-9	-7	242	2,498	476,202	637,643	1,437,401	87	14	9	5
Enterprise Value High	-25	-23	-13	-16	-9	-7	342	3,487	1,301,061	1,984,974	4,198,038	551	45	119	15
Enterprise Value Low	-25	-23	-13	-16	-9	-7	177	1,724	232,072	129,507	831,569	6	-1	-3	2

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	- -	- -	- -	- -
Revenue per Share	- -	- -	252.22	- -	- -	198.37	78,666	4,665.25	8.31	38.52	1.83	55,510.2	31,396.65	2,112.46	388.23
EBITDA per Share	-12,794.62	-20,204.54	-18,074.47	-19,886.39	-20,570.34	-18,802.52	-2,265,605.1	-227,754.69	-329.77	-36.2	-1.75	-103,110.2	-69,622.91	-3,526.05	-322.28
Operating Income per Share	-13,098.88	-20,450.68	-18,258.27	-20,027.79	-20,723.3	-18,931.25	-2,279,562.7	-229,952.68	-335.79	-40.56	-2.02	-111,155.1	-75,636.87	-3,563.53	-323.34
Basic EPS, GAAP	-14,046.47	-21,050.46	-18,996.03	-20,875.03	-21,156.86	-17,322.52	-2,336,084.4	-277,196.49	-1,110.39	-189.43	-3.51	-257,738.78	-129,089.39	-2,771.91	-345.75
Basic EPS from Cont Ops	-14,046.47	-21,050.46	-18,996.03	-20,875.03	-21,156.86	-17,322.52	-2,336,084.4	-249,707.56	-482.55	-189.43	-3.51	-257,738.78	-129,089.39	-2,771.91	-345.75
Diluted EPS, GAAP	-14,046.47	-21,050.46	-18,996.03	-20,875.03	-21,156.86	-17,322.52	-2,336,084.4	-277,196.49	-1,110.39	-189.43	-3.51	-257,738.78	-129,089.39	-2,771.91	-345.75
Diluted EPS from Cont Ops	-14,046.47	-21,050.46	-18,996.03	-20,875.03	-21,156.86	-17,322.52	-2,336,084.4	-249,707.56	-482.55	-189.43	-3.51	-257,738.78	-129,089.39	-2,771.91	-345.75
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-11,064.46	-16,142.05	-18,201.92	-14,919.62	-15,695.27	-15,357.36	-2,065,579.3	-201,542.69	-376.14	-36.25	-1.39	-62,755.1	-61,178.77	-4,128.53	-214.67
Free Cash Flow per Basic Share	-11,066.56	-16,346.32	-18,263.78	-15,256.47	-15,767.08	-15,383.8	-2,066,979.3	-202,666.65	-376.81	-36.28	-1.39	-62,755.1	-61,178.77	-4,128.53	-214.67
Cash & Equivalents per Share	24,972.11	23,881.05	18,063.79	18,864.36	9,408.23	5,385.35	331,078.7	83,304.98	75.91	7.49	0.48	92,918.37	10,768.16	1,085.44	33.6
Book Value per Share	-121,810.58	-142,789.3	-161,744.11	-182,443.37	-204,077.26	-188,573.04	-30,091,401.6	-2,743,927.93	-5,732.99	-1,258.99	-83.49	-2,359,073.47	-1,743,536.31	-154,716.16	-31,165.94
Tangible Book Value per Share	24,054.3	16,227.45	9,615.12	11,886.14	5,396.27	2,495.55	293,856.6	332,397.16	-72.04	-11.66	-2.03	95,946.94	9,500	1,621.96	-12.27

ReShape Lifesciences Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)